Resources for the IO Community

• CRI Immunotherapy Insights + Impact Report: The report synthesizes more than 150 U.S. FDA approvals from 2011 through 2024, offering a comprehensive view of how immunotherapy has evolved from a scientific breakthrough to standard of care across dozens of cancer types.  
• Nature Reviews Drug Discovery Business Brief: Cancer cell therapies: global clinical trial trends and emerging directions
• Interactive Tableau Dashboard: Companion to NRDD Cancer cell therapies publication
• CRI Data Programs: Learn about the new CRI Discovery Engine and our other programs, publications and collaborations

Sign up for our email newsletters to learn about new funding opportunities, immunotherapy research progress and patient perspectives.